Patients do not respond as expected to the immunotherapy, resulting in low efficacy.
Not applied to the appropriate patient, immunotherapies can cause serious side effects.
To study the presence of target molecules in the tumor, a biopsy is performed on the patient. However, this analysis provides a limited sample of the total information of the tumor and can lead to an inaccurate diagnosis.
of tumor analyzed. Extrapolating the results without knowing the whole presence of target molecules.
Performing a surgery on the patient to obtain a sample of the tumor.
of tumor analyzed. Getting conclusive and effective results.
A harmless method for the patient.
Our contrast agent. Composed of a radioactive isotope that emits radiation to obtain images from inside the body; a connector; and a carrier (antibody).
Radiotracers are injected into the patient and distributed throughout the body.
Like a magnet, they attach to the target molecules of cancer cells.
A mapping of all the tumor cells potentially vulnerable to treatment is created.
All these cells are visible through a medical image thanks to the radiation of the radiotracers.
After radiotracers attach to target molecules, a medical imaging shows emitted radiation.
This radiation reveal the exact location of target molecules, which aids in diagnosis and treatment planning.
